iKang Healthcare Group, China's largest private operator of medical exam and disease screening centers, raised $153 million by offering 10.9 million shares (31% insider) at $14, the high end of the range of $12 to $14. iKang Healthcare Group plans to list on the NASDAQ under the symbol KANG. iKang Healthcare Group initially filed confidentially on 12/4/2013. BofA Merrill Lynch and UBS Investment Bank acted as lead managers on the deal.
